Compare · ILMN vs OSCR
ILMN vs OSCR
Side-by-side comparison of Illumina Inc. (ILMN) and Oscar Health Inc. (OSCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and OSCR operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $24.56B, about 3.3x OSCR ($7.39B).
- ILMN has been more active in the news (21 items in the past 4 weeks vs 11 for OSCR).
- Both have 25 recent analyst ratings on file.
- Company
- Illumina Inc.
- Oscar Health Inc.
- Price
- $162.28-3.39%
- $24.50+3.90%
- Market cap
- $24.56B
- $7.39B
- 1M return
- -
- +23.70%
- 1Y return
- -
- +66.08%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2000
- 2021
- News (4w)
- 21
- 11
- Recent ratings
- 25
- 25
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Oscar Health Inc.
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a full stack technology platform. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was founded in 2012 and is headquartered in New York, New York.
Latest ILMN
- SVP, Chief People Officer Leckman Patricia sold $127,068 worth of shares (784 units at $162.08), decreasing direct ownership by 3% to 22,042 units (SEC Form 4)
- Director Meister Keith A. sold $107,042,631 worth of shares (669,596 units at $159.86) (SEC Form 4)
- Chief Legal Officer Davies Scott M sold $98,400 worth of shares (615 units at $160.00), decreasing direct ownership by 3% to 21,568 units (SEC Form 4)
- VP, Chief Accounting Officer Ericksen Scott D sold $305,150 worth of shares (2,000 units at $152.57), decreasing direct ownership by 12% to 14,446 units (SEC Form 4)
- Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
- Amendment: SEC Form 4 filed by Director Meister Keith A.
- Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
- Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
- Illumina Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director King David P was granted 2,072 shares (SEC Form 4)
Latest OSCR
- Chief Accounting Officer Baltrus Victoria sold $33,417 worth of shares (1,523 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 0.70% to 214,589 units (SEC Form 4) to satisfy tax liability
- Director Schlosser Mario sold $748,633 worth of shares (34,120 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 480,866 units (SEC Form 4) to cover withholding tax
- Chief Legal Officer Mcananey Adam sold $216,318 worth of shares (9,859 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 218,096 units (SEC Form 4) (tax withholding)
- President, Oscar Insurance Liang Janet sold $273,716 worth of shares (12,475 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 259,057 units (SEC Form 4) (tax withholding)
- Chief Financial Officer Blackley Richard Scott sold $695,162 worth of shares (31,683 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,074,977 units (SEC Form 4) (tax withholding)
- Oscar Health upgraded by Wells Fargo with a new price target
- SEC Form 144 filed by Oscar Health Inc.
- Oscar Health Inc. filed SEC Form 8-K: Leadership Update
- Chief Financial Officer Blackley Richard Scott sold $2,753,300 worth of shares (110,000 units at $25.03) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 1,106,660 units (SEC Form 4)
- SEC Form 144 filed by Oscar Health Inc.